We regularly bring together leaders in the fight against ALS to share the latest developments in the work being done to make ALS livable for everyone, everywhere until we find a cure.
The ALS Association submitted comments to the FDA’s Central and Peripheral Nervous System Advisory Committee, urging it to recommend approval of tofersen for people with ALS linked to a SOD1 gene mutation. The committee will meet virtually on March 22 to review data associated with Biogen’s new drug application.